ArticleEndocrine pathology2018

Argininosuccinate Synthetase-1 (ASS1) Loss in High-Grade Neuroendocrine Carcinomas of the Urinary Bladder: Implications for Targeted Therapy with ADI-PEG 20.

Sounak Gupta et al.PubMed ↗Publisher ↗

No numbers read from the abstract.